Table 3.
Use of anti-inflammatory drugs by cases and controls
| Patient characteristics | Cases first admission n = 285 (%) | Cases recurrent admissions n = 245 (%) | Controls n = 1054 (%) |
|---|---|---|---|
| Any anti-inflammatory drug | 81 (28.4) | 38 (15.5) | 249 (23.6) |
| Selective COX-2 inhibitors* | 53 (18.6) | 20 (8.2) | 160 (15.2) |
| Other NSAIDs | 28 (9.8) | 18 (7.3) | 89 (8.4) |
| Celecoxib | 25 (8.8) | 7 (2.9) | 73 (6.9) |
| Rofecoxib | 26 (9.1) | 11 (4.5) | 79 (7.5) |
| Naproxen | 6 (2.1) | 4 (1.6) | 26 (2.5) |
| Diclofenac | 5 (1.7) | 6 (2.4) | 22 (2.1) |
| Ibuprofen | 9 (3.2) | 8 (3.3) | 33 (3.1) |
| Meloxicam | 2 (0.7) | 2 (0.8) | 14 (1.3) |
| Paracetamol | 182 (63.9) | 160 (65.3) | 707 (67.1) |
| Glucocorticoids | 25 (8.8) | 17 (6.9) | 131 (12.4) |
*
Celecoxib, rofecoxib, meloxicam.